VERALOX THERAPEUTICS
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
VERALOX THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Frederick, Maryland, United States
Country:
United States
Website Url:
http://www.veralox.com
Total Employee:
1+
Status:
Active
Contact:
(301) 360-3502
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Nginx Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Naegis Pharmaceuticals
Naegis Pharmaceuticals is driven to discover new therapies that target underlying chronic inflammatory processes in eye diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
TEDCO
TEDCO investment in Series A - Veralox Therapeutics
(Momentum Fund) University System of Maryland
(Momentum Fund) University System of Maryland investment in Series A - Veralox Therapeutics
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Veralox Therapeutics
Point Field Partners
Point Field Partners investment in Series A - Veralox Therapeutics
Virginia Tech Carilion (VTC) Innovation Fund
Virginia Tech Carilion (VTC) Innovation Fund investment in Series A - Veralox Therapeutics
Alumni Ventures
Alumni Ventures investment in Series A - Veralox Therapeutics
JDRF T1D Fund
JDRF T1D Fund investment in Series A - Veralox Therapeutics
Genesys Capital
Genesys Capital investment in Series A - Veralox Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Veralox Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series A - Veralox Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-02-23 | Veralox Therapeutics Appoints Lisa Beck as Chief Business Officer |
Official Site Inspections
http://www.veralox.com
- Host name: ec2-54-157-188-110.compute-1.amazonaws.com
- IP address: 54.157.188.110
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149